ARMATA PHARMACEUTICALS, INC. Accrued Liabilities, Current
ARMATA PHARMACEUTICALS, INC. (ARMP) had Accrued Liabilities, Current of $1.75 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2018-11-08
- 2018-09-30: Accrued Liabilities, Current $1.75M.
- 2018-06-30: Accrued Liabilities, Current $1.37M.
- 2018-03-31: Accrued Liabilities, Current $965.00K.
- 2017-12-31: Accrued Liabilities, Current $1.39M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2018-09-30 | $1.75M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.37M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $965.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.39M 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |